TNFRSF18 and hepatocellular carcinoma: Similarly, the glucocorticoid-induced tumor necrosis factor receptor (GITR) expression profile in the HCC microenvironment needs to be elucidated for DTA-1 (a GITR-agonistic antibody) therapy [81].